小剂量螺内酯治疗顽固性高血压病的疗效和安全性
《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]
- 期数:
- 2011年第6期
- 页码:
- 822-823
- 栏目:
- 短篇
- 出版日期:
- 2011-12-25
文章信息/Info
- Title:
- -
- Author(s):
- -
- Keywords:
- -
- 分类号:
- R544.1
- DOI:
- -
- 文献标识码:
- B
- 摘要:
- -
- Abstract:
- -
参考文献/References
[1]Mancia G,de Backer G,Dominiczak A,et al.2007 Guidelines for the management of arterial hypertension:the Fask Force for the Management of Arteria Hypertension of the European society of Hypertension(Esc)[J].Eur heart J,2007,28(12):1462-1536.
[2]Moster M,staro JF.Resistant or difficult-to-control hypertension hypertension[J].N Engl J Med,2006,355(4):385-392.
[3]Ubaid-Girioli S,Ferreira-Melo SE,Souza LA,et al.Aldosterone escape with diuretic or angiotension-converting enzyme inhibitor/angitensioⅡreceptor blocker combination therapy in patients with mild to moderate hypertension[J].J Clin hypertens (Greenwich),2007,9(10):770-774.
[4]Miyazaki M,Takai S.Tissue angiotensionⅡgenerating system by angiotension-converting enzyme and chymase[J].J Pharmacol Sci,2006,100(5):391-397.
[5]Ouzan J,Perault C,Lincoff AM,et al. The role of spironolactone in the treatment of patients with refractor hypertension[J].Am J Hypertens,2002,15(4)925-930.
[6]Nishizaka MK,zaman MA,Calhoun DA.Efficacy of low-dose spironolacton in subjects with resistant hypertension[J].Am J Hypertens,2003,16(11pt1):925-930.
[7]Mahmud A,Mahgoub M,Hall M,et al.Dose aldosterone-to-renin radio predict the antihypertensive effect of the aldosterone antagonist spironolactone[J].Am J Hypertens,2005, 18(12pt1):1631-1635.
备注/Memo
- 备注/Memo:
- 收稿日期：2011-01-20.
常用功能
统计/Statistics
- 摘要浏览/Viewed932
- 评论/Comments
